Foulston Matthew J. 4

What Happened
Matthew J. Foulston, a director of Trulieve Cannabis Corp. (TRUL), was granted 23,438 restricted stock units (RSUs) on 2026-03-13. The Form 4 lists the acquisition price as $0.00 (reported acquisition value $0), reflecting that these are equity awards rather than a cash purchase. The RSUs represent a contingent right to receive one Trulieve subordinate voting share per RSU upon vesting.

Key Details

• Transaction date: 2026-03-13; Form 4 filed 2026-03-17 (filed within the standard two-business-day window).
• Security/amount: 23,438 RSUs; reported price per unit $0.00 (award/grant, code A).
• Shares owned after transaction: Not specified in the filing.
• Vesting (per footnote): RSUs vest on the earliest of (i) end of the reporting person’s board service, (ii) a change of control of Trulieve, or (iii) December 1, 2032.
• Filing timeliness: Timely filed (not marked late).

Context
RSUs are a form of compensation that convert to actual shares only if and when they vest; no shares were immediately sold or purchased in this transaction. The economic value of the award will depend on Trulieve’s stock price at the time the RSUs vest or are settled. Grants to directors are common and are administrative/compensation events rather than direct buy/sell signals; any future sale or acquisition of the underlying shares would be reported separately.